Global Drug Discovery Technologies Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Drug Discovery Technologies Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
This report mainly focuses on drug discovery technologies marekt. Current drug discovery technologies aims to discover all the modern techniques and technologies used in drug discovery.
Global Drug Discovery Technologies market is projected to reach US$ 76370 million in 2033, increasing from US$ 48000 million in 2022, with the CAGR of 6.7% during the period of 2023 to 2033. Demand from Pharmaceutical Companies and Research Institutes are the major drivers for the industry.
Regionally, North America will dominate the global drug discovery technologies market in 2022. Countries such as the United States lead the world in R&D spending. Furthermore, increasing demand for advanced and innovative medicines due to increasing prevalence of chronic diseases is driving the growth of the drug discovery market in North America. Asia Pacific is estimated to be the most opportunistic market in the coming years. This can be attributed to the presence of numerous CROs in the region. Moreover, countries such as South Korea, India, and China are investing heavily in the development of the pharmaceutical industry, which is fueling the demand for biopharmaceutical products.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Drug Discovery Technologies market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Agilent
GE Healthcare
Albany Molecular Research Inc.
Affymetrix
Bayer Healthcare
Novartis
AstraZeneca
Segment by Type
Small-molecule Drugs
Biologics
Pharmaceutical Companies
Research Institutes
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Drug Discovery Technologies market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Drug Discovery Technologies introduction, etc. Drug Discovery Technologies Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Drug Discovery Technologies market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Global Drug Discovery Technologies market is projected to reach US$ 76370 million in 2033, increasing from US$ 48000 million in 2022, with the CAGR of 6.7% during the period of 2023 to 2033. Demand from Pharmaceutical Companies and Research Institutes are the major drivers for the industry.
Regionally, North America will dominate the global drug discovery technologies market in 2022. Countries such as the United States lead the world in R&D spending. Furthermore, increasing demand for advanced and innovative medicines due to increasing prevalence of chronic diseases is driving the growth of the drug discovery market in North America. Asia Pacific is estimated to be the most opportunistic market in the coming years. This can be attributed to the presence of numerous CROs in the region. Moreover, countries such as South Korea, India, and China are investing heavily in the development of the pharmaceutical industry, which is fueling the demand for biopharmaceutical products.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Drug Discovery Technologies market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Agilent
GE Healthcare
Albany Molecular Research Inc.
Affymetrix
Bayer Healthcare
Novartis
AstraZeneca
Segment by Type
Small-molecule Drugs
Biologics
Segment by Application
Pharmaceutical Companies
Research Institutes
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Drug Discovery Technologies market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Drug Discovery Technologies introduction, etc. Drug Discovery Technologies Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Drug Discovery Technologies market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.